Back

Coronin1A regulates tumor microenvironment in colitis-associated colorectal cancer in a SUMO-dependent way

Srikanth, C.; Babar, R.; Saini, P.; Guliya, N.; Kumar, V. E.; Varshney, P.; Suhail, A.; Singh, M.; Mujagond, P.; Tyagi, S.; Mehra, L.; Jain, D.; Das, P.; Pieters, J.; Krishnan, V.; Bajaj, A.; Ahuja, V.

2026-02-17 cancer biology
10.64898/2026.02.16.706097 bioRxiv
Show abstract

Inflammatory bowel disease (IBD), comprising Crohns disease and Ulcerative colitis, is a group of multifactorial illnesses with persistent gastrointestinal inflammation and a series of undesirable consequences. IBD patients have a three times higher risk of developing colitis-associated colorectal cancer (CAC). A higher mutational burden due to persistent inflammation acts as a driver of dysplasia and even tumorigenesis. While the pathological sequence is known, the molecular mechanisms underlying the transition from chronic inflammation to CAC remain largely elusive. Post-translational modification- SUMOylation plays an integral role in shaping gut inflammation as well as several forms of cancers, including sporadic colorectal cancer. In this study, the contribution of SUMOylation to CAC pathogenesis was characterized. In the AOM-DSS CAC mice model and human IBD patient specimens, SENP5, but not other deSUMOylases, shows an altered expression. Notably, both SENP5 expression dynamics and alterations in the SUMOylome occur in chronically inflamed and neoplastic colon tissues. SENP5 interactome analysis identified Coronin1A (Coro1A), an actin-binding protein predominantly expressed in immune cells. Coro1A also shows a state-specific, distinct expression pattern in the colon. Interestingly, in contrast to wild-type mice, Coro 1A knockout mice were resistant to polyp formation, with reduced cell proliferation, oncogene expression, and epithelial-to-mesenchymal transition (EMT) gene activation, and reduced extracellular matrix (ECM) development and fibrosis, suggesting its integral role in tumorigenesis. WT mice with chronically inflamed colons and polyps have a higher number of M2-like macrophages, with increased abundance of Coro1A, suggesting a role of Coro1A in modulating the tissue microenvironment toward a pro-tumorigenic state. Mechanistically, Coro1A physically interacts with TGF-{beta} RI and regulates TGF-{beta}-TGF-{beta} RI signalling endosome stability, thereby controlling TGF-{beta}-mediated macrophage polarization. Detailed in vitro experiments revealed stabilization of Coro 1A through its interaction with SUMOylated Raftlin protein. Overall, Coro 1A is necessary and sufficient for TGF-{beta} signalling, macrophage polarization, and tumorigenesis in CAC.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Gastroenterology
40 papers in training set
Top 0.2%
10.1%
2
Gut
36 papers in training set
Top 0.1%
8.4%
3
Cell Reports
1338 papers in training set
Top 5%
7.2%
4
Nature Communications
4913 papers in training set
Top 35%
4.3%
5
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.1%
4.0%
6
Oncogene
76 papers in training set
Top 0.5%
3.6%
7
Cell Death & Disease
126 papers in training set
Top 0.3%
3.6%
8
Developmental Cell
168 papers in training set
Top 6%
3.1%
9
JCI Insight
241 papers in training set
Top 2%
2.6%
10
Journal of Clinical Investigation
164 papers in training set
Top 2%
2.6%
11
EMBO reports
136 papers in training set
Top 2%
1.9%
50% of probability mass above
12
Cell Death & Differentiation
48 papers in training set
Top 0.2%
1.8%
13
International Journal of Molecular Sciences
453 papers in training set
Top 8%
1.7%
14
Advanced Science
249 papers in training set
Top 11%
1.7%
15
The EMBO Journal
267 papers in training set
Top 2%
1.7%
16
Cell Communication and Signaling
35 papers in training set
Top 0.5%
1.5%
17
Signal Transduction and Targeted Therapy
29 papers in training set
Top 0.9%
1.3%
18
Frontiers in Immunology
586 papers in training set
Top 5%
1.2%
19
eLife
5422 papers in training set
Top 49%
1.2%
20
Redox Biology
64 papers in training set
Top 0.6%
1.2%
21
Cancer Research
116 papers in training set
Top 3%
1.2%
22
Scientific Reports
3102 papers in training set
Top 68%
1.1%
23
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 6%
1.1%
24
Clinical and Translational Medicine
30 papers in training set
Top 0.6%
0.9%
25
Cell Reports Medicine
140 papers in training set
Top 6%
0.9%
26
EMBO Molecular Medicine
85 papers in training set
Top 3%
0.9%
27
The FASEB Journal
175 papers in training set
Top 2%
0.9%
28
Genome Medicine
154 papers in training set
Top 7%
0.9%
29
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 43%
0.8%
30
Cancers
200 papers in training set
Top 5%
0.7%